Alex Bica, MD, MPH, ExecMSc (Hons), FRSPH
Benefit–risk and drug safety consulting for pharma and biotech
Defensible benefit–risk decisions for pharma and biotech.
Senior scientific advisory in translational safety, clinical development, and decision intelligence.
20+ years bridging nonclinical science, clinical development, and regulatory decision-making.
Why Development Programs Stall
The problem is rarely missing data. It’s poorly structured uncertainty.
Safety Assumptions Lost in Translation
Early safety hypotheses are generated but never formally carried into clinical development. Critical assumptions go untested.
Protocols Without Trade-Off Analysis
Clinical protocols are designed without explicit benefit–risk framing. Decisions are made, but the reasoning is not documented.
Governance Without Traceability
Boards and regulators receive conclusions, not the structured reasoning behind them. Decisions lack defensibility.
Data accumulates. Decision clarity does not.
I bring structured reasoning to every stage of drug development — so that decisions are not just made, but made defensibly.
What Makes Me Different
Decision-Centric by Design
Every engagement is structured around the decisions you need to make — not around deliverables or reports.
Integrated Across Development
Translational safety, clinical evidence, and governance are treated as a unified architecture, not separate workstreams.
Explicit About Uncertainty
I make assumptions, trade-offs, and probability ranges transparent. No hidden reasoning.
Governance-Ready Outputs
Everything I produce is designed for regulatory, board, and investor scrutiny from day one.
My Services
Focused expertise across four pillars of drug development safety.
Early Development & Translational Safety
Defensible FIH dose rationale, translational safety strategy, and independent senior safety oversight for emerging programs.
Clinical Development & Evidence Strategy
Protocol risk framing, epidemiology and real-world evidence integration, and regulatory-aligned safety arguments.
Training & Capacity Building
Technical specialist tracks, project team workshops, and executive leadership programs in decision science under uncertainty.
Decision Intelligence Framework
Explicit uncertainty mapping, trade-off documentation, and assumption tracking across development stages.
How I Work
A lifecycle approach that ensures decision logic is built in from the start — not retrofitted at the end.
Understand
I map your development landscape: safety assumptions, evidence gaps, and the decisions ahead.
Structure
I build an explicit decision architecture with documented reasoning, trade-offs, and uncertainty.
Defend
I deliver governance-ready outputs that stand up to regulatory, board, and investor scrutiny.
Who I Work With
Early-Stage Biotech
Approaching first-in-human studies and needing robust safety architecture.
Lean Development Organizations
Teams without dedicated safety physicians who need senior-level strategic oversight.
Programs with Safety Signals
Development programs where emerging signals require expert contextualization and structured responses.
Boards & Investors
Governance bodies requiring independent safety assurance and defensible decision documentation.
Credibility in drug development is built one defensible decision at a time.
Let’s Discuss Your Challenge